Navigation Links
Albert Einstein Cancer Center begins 40th year of continuous NIH support with $17 million grant
Date:9/26/2013

September 26, 2013 (BRONX, NY) For the past four decades, scientists and clinicians at Albert Einstein Cancer Center (AECC) have made major contributions to research on many aspects of the cancer problem. With the recent renewal of the center's $16.7 million grant from the National Cancer Institute (NCI), AECC members will continue to investigate the underlying causes of cancer and new approaches to the prevention, diagnosis and treatment of these diseases.

"Our faculty is pleased and proud to have competed so favorably in the peer-review process that resulted in the renewal of this grant, particularly at a time of diminishing NCI support for cancer research," said I. David Goldman, M.D., director of AECC at Albert Einstein College of Medicine of Yeshiva University. Dr. Goldman is also professor of medicine and of molecular pharmacology and holds the Susan Resnick Fisher Chair at Einstein.

AECC was one of the first academic cancer research centers to receive an NCI designation, which it has held since 1972. Currently, there are 68 such centers throughout the United States. Since AECC's creation, its researchers have made notable fundamental scientific discoveries that have elucidated why cancers form, grow and spread. AECC's clinical scientists are developing novel approaches to cancer treatment and the center's epidemiologists are making major contributions to the understanding of the viral and other environmental causes of cancer and its prevention. AECC is a national resource for these studies given the diverse ethnic and racial populations in the Bronx.

This grant will provide continued support for five ongoing interdisciplinary research programs that form the basis of AECC's laboratory and translational work: tumor microenvironment and metastasis; stem cells, differentiation and cancer; experimental therapeutics; cancer epidemiology; and the biology of colon cancer. These research programs are supported by 14 specialized shared resource facilities that range from genomics and proteomics to biostatistics and bioinformatics. AECC also provides comprehensive support for, and oversight of, its clinical cancer research activities conducted at the Montefiore-Einstein Center for Cancer Care.


'/>"/>

Contact: Deirdre Branley
sciencenews@einstein.yu.edu
347-266-9204
Albert Einstein College of Medicine
Source:Eurekalert

Related medicine news :

1. UAlberta prostate cancer researcher and team developing homing beacon drugs to target cancer cells
2. UAlberta medical researchers make key discovery in fight against Alzheimers disease
3. UAlberta medical researchers discover new potential chemotherapy
4. Alternative medicine use high amoung children with chronic conditions: UAlberta medical research
5. Alternative medicine use high among children with chronic conditions: UAlberta medical research
6. New UAlberta research shows commonly prescribed medications could have adverse effects
7. UAlberta researcher pinpoints prescription for successful Primary Care Networks
8. Albertson & Davidson, LLP Obtains Court Order Requiring California Trustee to Provide Pre-Death Accounting
9. Dr. Anne Gershon receives 2013 Albert B. Sabin Gold Medal Award
10. Stadler Form’s Revolutionary Dehumidifier, Albert, Makes Its Debut at Humidifiers.com
11. DiscountFurnaceFilter.com Introduces the Latest Innovative Creation from Stadler Form, Albert the Dehumidifier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... ... The Lung Institute has partnered with the Gulfcoast North Area ... at their clinic in downtown Tampa. The class is complimentary for the public. Register ... a free downloadable 4 Week Smoking Cessation Guide for those who are ...
(Date:5/26/2016)... ... 26, 2016 , ... American orthopedic surgeon and internationally recognized ... Horizon International (BHI), Brian Mehling, M.D., spoke at an International Conference and Expo ... in Chicago, IL, USA. Dr. Mehling’s presentation was focused on stem cell therapy ...
(Date:5/26/2016)... TN (PRWEB) , ... May 26, 2016 , ... ... fitness education and products recently hosted the first PowerWave Instructor Certification Course in ... who lead a group of fitness professional through the 8 hour interactive course ...
(Date:5/26/2016)... ... 2016 , ... On May 23rd during the National Eye Institute’s “Healthy Vision ... advocate, was honored by Ashram, Inc. as the world’s foremost water visionary. , “Sharon ... banks of the Nile to fill their red clay pots with life-sustaining water.” Said ...
(Date:5/26/2016)... ... May 26, 2016 , ... Workrite Ergonomics ... leadership and to further develop their rapidly expanding portfolio of customer and end ... a concentration in Marketing and an M.B.A. with concentration in management from Bryant ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 /PRNewswire/ ... Frankfurt Prime Standard: QIA) today announced that the company has ... GmbH to develop and commercialize predictive assays in oncology. An ... a marker to predict effectiveness of anthracycline treatment in triple ... are pleased to partner with Therawis, which developed the PITX2 ...
Breaking Medicine Technology: